At present, the Healgen rapid COVID-19 antigen test is being rolled out on a wide scale by the UK Government to aid the mass-testing effort. Although the test is designed for use by clinical professionals such as doctors and nurses, an application for “exceptional use” of the COVID-19 testing kit by members of the public in domestic settings was approved on December 23rd by the Medicines and Healthcare Regulatory Agency (MHRA).

The Healgen COVID-19 Antigen Test has been evaluated with specimens obtained from patients and the results show that the rapid COVID-19 test has a high overall relative accuracy. Healgen Tests UK

COVID-19 is an acute respiratory infectious disease, and humans are generally susceptible. Currently, the patients infected by COVID-19 are the main source of infection and the disease is spreading rapidly around the world. COVID-19 is especially problematic as the majority of those infected are asymptomatic, meaning that they don’t display symptoms and unknowingly spread the virus around. Based on current epidemiological investigations, COVID-19’s incubation period is 1 to 14 days, with most infections taking hold within 3 to 7 days. The main symptoms of the disease include a new or continuous dry cough, a loss of taste or smell, fatigue, and a temperature or fever.

During the acute phase of the COVID-19 infection, antigens are generally detectable in the upper respiratory tract. Rapid diagnoses of COVID-19 will help healthcare professionals treat patients, control the virus more efficiently, and save lives. Healgen Corona Test

The Healgen COVID-19 Antigen Test is an in vitro immunochromatographic assay for the detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens after the swabs have been added to the virtual transport media from individuals who are suspected of having COVID-19. It is intended to aid in the quick diagnosis of the SARS-CoV-2 infection so as to identify positive cases, isolate those who have it, control the virus, and save lives.